The importance of metabolic dysfunction in polycystic ovary syndrome

被引:0
作者
Jenny A. Visser
机构
[1] Erasmus MC,Department of Internal Medicine
[2] University Medical Center Rotterdam,undefined
来源
Nature Reviews Endocrinology | 2021年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder characterized by reproductive and metabolic disturbances. Androgen excess is a hallmark of PCOS, driving many of the phenotypic features. In 2020, several findings highlight altered metabolic pathways as an underlying biological mechanism in PCOS. These findings add to our understanding of the complex interaction between metabolic homeostasis and reproduction.
引用
收藏
页码:77 / 78
页数:1
相关论文
共 50 条
  • [31] Transgenerational transmission of reproductive and metabolic dysfunction in the male progeny of polycystic ovary syndrome
    Risal, Sanjiv
    Li, Congru
    Luo, Qing
    Fornes, Romina
    Lu, Haojiang
    Eriksson, Gustaw
    Manti, Maria
    Ohlsson, Claes
    Lindgren, Eva
    Crisosto, Nicolas
    Maliqueo, Manuel
    Echiburu, Barbara
    Recabarren, Sergio
    Petermann, Teresa Sir
    Benrick, Anna
    Brusselaers, Nele
    Qiao, Jie
    Deng, Qiaolin
    Stener-Victorin, Elisabet
    CELL REPORTS MEDICINE, 2023, 4 (05)
  • [32] The importance of insulin resistance in polycystic ovary syndrome
    Goodarzi, MO
    Korenman, SG
    FERTILITY AND STERILITY, 2003, 80 (02) : 255 - 258
  • [33] The importance of inflammation markers in polycystic ovary syndrome
    Ozay, Ali Cenk
    Ozay, Ozlen Emekci
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (03): : 411 - 417
  • [34] Polycystic ovary syndrome:: The importance of establishing diagnosis
    Sir-Petermann, T
    Maliqueo, M
    Pérez-Bravo, F
    Angel, B
    Carvajal, F
    del Solar, MP
    Benítez, R
    REVISTA MEDICA DE CHILE, 2001, 129 (07) : 805 - 812
  • [35] Screening women with polycystic ovary syndrome for metabolic syndrome
    Dokras, A
    Bochner, M
    Hollinrake, E
    Markham, S
    VanVoorhis, B
    Jagasia, DH
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) : 131 - 137
  • [36] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Alessandro P. Delitala
    Giampiero Capobianco
    Giuseppe Delitala
    Pier Luigi Cherchi
    Salvatore Dessole
    Archives of Gynecology and Obstetrics, 2017, 296 : 405 - 419
  • [37] Pancreatic β-cells dysfunction in polycystic ovary syndrome
    Diamanti-Kandarakis, E.
    Xyrafis, X.
    Boutzios, G.
    Christakou, C.
    PANMINERVA MEDICA, 2008, 50 (04) : 315 - 325
  • [38] Autonomic dysfunction in women with polycystic ovary syndrome
    Hashim, Zainab Hasan
    Hamdan, Farqad Bader
    Al-Salihi, Anam Rashid
    INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE, 2015, 13 (01) : 27 - 34
  • [39] Polycystic Ovary syndrome Metabolic Syndrome Predisposition in Puberty
    Geronikolou, Styliani
    Bacopoulou, Flora
    Chryssanthopoulos, Stavros
    Cokkinos, Dennis
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 485 - 485
  • [40] The effect of exenatide on metabolic syndrome with polycystic ovary syndrome
    Chen, Lin
    Long, Tao
    Zheng, Siyuan
    Liu, Xin
    Yan, Jiahe
    Mai, Tingting
    Gong, Yi
    Liu, En
    Xie, Yijuan
    Chen, Hui
    Lin, Rong
    Zheng, Yongxiong
    Luo, Hengcong
    Zhang, Ying
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33